Where does Lung Biotechnology PBC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lung Biotechnology PBC ranks #17,867 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lung Biotechnology PBC hold?

Lung Biotechnology PBC holds 16 US utility patents granted between 2015 and 2025, spanning 17 technology areas.

What is Lung Biotechnology PBC's Innovation Score?

Lung Biotechnology PBC has an Innovation Score of 37.3 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lung Biotechnology PBC focus on?

Lung Biotechnology PBC's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 9 patents, ranking #496 of 2,691 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

Is Lung Biotechnology PBC's patent grant rate increasing or decreasing?

Lung Biotechnology PBC's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lung Biotechnology PBC's patents?

Lung Biotechnology PBC's patents average 10.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lung Biotechnology PBC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lung Biotechnology PBC

USPTO PatentsView assignee record - 16 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lung ranks #17,867 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 17 technology areas.

#17,867
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.3/100): 10.5
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17867 · US Corporation #17,867 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,867/49,997
PHOTO-FINISH Loctek
CPC-FOCUS C07C · 17 areas
INNOV-THIN 37.3/100
CLAIMS-PAR 10.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Loctek Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lung’s 37.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (26%) Velocity 6.7 pts (18%) Breadth 14.6 pts (39%) Claim depth 6.3 pts (17%)

Qualcomm Incorporated · highest

85
Lung Biotechnology PBC · this assignee

37
3D Lighting… · lowest

7

What this shows Lung's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lung?

Each dot is one of Lung’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lung’s own 10.5 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Lung vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lung's grants concentrate

Lung Biotechnology PBC is a focused PatentsView assignee: 17 CPC subclasses with 56.3% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2015. By volume, Lung sits between Loctek Inc. and Marvel Technology (CHINA) Co., Ltd.

Lung's three-year grant acceleration

Lung Biotechnology PBC shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Loctek

16
Logmeln

16
Loop Now

16
Lubris

16
M Squared Lasers

16
Mafin S R L

16
Marel Salmon A/S

16
Marvel Technology…

16
Lung Biotechnolog… ◀

16

What this shows Lung holds 16 patents at rank #17,865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lung

By rank, the assignees closest to #17,865 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Lung's primary technology class.

Lung's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lung Biotechnology PBC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	6.3%
2016	1	6.3%
2017	2	12.5%
2018	2	12.5%
2019	2	12.5%
2020	2	12.5%
2023	1	6.3%
2024	3	18.8%
2025partial year	2	12.5%

Which technologies does Lung Biotechnology PBC patent most?

C07C - Acyclic OR Carbocyclic Compounds 9

C07D - Heterocyclic Compounds 9

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 9

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 5

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07K - Peptides 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

G06T - Image Data Processing OR Generation, IN General 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lung Biotechnology PBC's patent record in context - here's where to go next.

Lung Biotechnology PBC's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 56.3% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #17,867 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lung Biotechnology PBC against Loctek Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.